Taprenepag T3174
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Taprenepag (CP-544326) is a potent and selective prostaglandin E2 receptor agonist (EC50 = 2.8 nM). Taprenepag has been used in trials studying the treatment of Ocular Hypertension and Glaucoma, Open-Angle.
CAS nr:
752187-80-7
Purity:
98%
Molecular Weight:
478,52
SMILES:
c1cc(cc(c1)OCC(=O)O)CN(Cc1ccc(cc1)n1cccn1)S(=O)(=O)c1cnccc1
Formula:
C24H22N4O5S
Pathway:
GPCR/G Protein,Immunology/Inflammation
Target:
Prostaglandin Receptor,Prostaglandin Receptor
